Realistic Pulmonary Delivery System Trainers: Benefits for Patients, Physicians and Pharma

The use of training devices has been shown to improve correct inhalation device technique in patients. In this article, Craig Baker, Executive Vice-President, Noble, discusses the prevalence of improper use and how addressing this issue via training devices is of benefit to manufacturers, healthcare providers and patients. http://www.ondrugdelivery.com/publications/85/Noble.pdf

Integrating patient training into product launches

Product launch is a critical moment in a brand’s ultimate success. Product launches for pharmaceuticals are complex and differ in many ways from other industries, with multiple key players such as research and development, formulation specialists, analysts, regulatory affairs, device engineers, commercial/brand teams, and many others intimately involved. This process takes on additional complexity [...]

Noble Company Profile

Noble®, the leader in onboarding and device training, is a full-service, patient-centred product development and manufacturing company. Noble works closely with the world’s leading pharmaceutical and biotechnology companies to develop educational and training solutions designed to provide positive patient onboarding experiences, reduce errors and improve patient outcomes. Cross-disciplinary designers and engineers provide fully customised [...]

Connecting the Dots to Connected Health

As the mHealth market grows, the industry prepares to optimize digital opportunities. Measuring easily quantifiable data is one of the keys to better health. Therefore, the future belongs to digestible, embedded, and wearable sensors that work like a thin e-skin. These sensors will measure all important health parameters and vital signs —for example, temperature, [...]

Considering Human Factors And Training In Medical Device Design

The patient has become the end user when it comes to many types of medical technology, and that trend is likely to continue with the rise of mobile health (mHealth), remote patient monitoring, and other healthcare industry drivers. As a result, the human factor is becoming increasingly important in the design of next-generation medical [...]

How to Establish Brand Preference Among HCPs

In recent years, environmental factors have changed the way products are launched and managed throughout the lifecycle. The Sunshine & HITECH Acts, as well as the emergence of new device and formulation technologies, pose opportunities and risks to marketers looking to gain access, build loyalty and balance portfolios. Read More > [...]

Educating Patients on Self-administered Drug Injections

With the time and resources invested in developing and evaluating new drugs through clinical trials, the reality is much of a new treatment's success is dependent on patients' ability to comprehend and adhere to the instructions for use (IFU) supplied by the manufacturer and approved by the FDA.  Read More > [...]

Streamlining Combination Device Development

New product launches are exciting times for manufactures bringing new products to market and patients awaiting new treatments. In recent years, innovation has resulted in new regulatory structures and processes for evaluating products prior to entering the market. An example of this is the formation of the Office of Combination Products (FDA - 2002) [...]

Building in Education – Multisensory Training for Patients

As FDA works to ensure medical device safety and effectiveness, the agency is urging manufacturers to utilize human factors engineering during product design. After all, FDA’s Quality System Regulation on Design Controls “implies” the need for human factors, pointed out Molly Follette Story of FDA’s CDRH/ODE in a June 2012 Webinar with RAPS. And [...]

Special Delivery – Challenges and Opportunities in Patient Onboarding

The issues of patient safety and device usability have become hot topics in the drug-delivery market as healthcare costs continue to rise, while adherence rates have fallen to 50 percent. This strain on the healthcare system has led to stricter regulations and scrutiny for companies bringing new biologic or biosimilar products to market. Many [...]